$12,500 of SCPHARMACEUTICALS INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medicare reimbursement of pharmaceuticals general issues of interest to pharmaceutical companies"
You can find more data on corporate lobbying on Quiver Quantitative.
SCPH Insider Trading Activity
SCPH insiders have traded $SCPH stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SCPH stock by insiders over the last 6 months:
- ADVISORS LLC ORBIMED has traded it 2 times. They made 2 purchases, buying 500,000 shares and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SCPH Hedge Fund Activity
We have seen 55 institutional investors add shares of SCPH stock to their portfolio, and 29 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUVRETTA CAPITAL MANAGEMENT, LLC added 2,049,009 shares (+inf%) to their portfolio in Q3 2024
- RUBRIC CAPITAL MANAGEMENT LP added 1,250,000 shares (+35.5%) to their portfolio in Q3 2024
- KINGDON CAPITAL MANAGEMENT, L.L.C. added 800,000 shares (+inf%) to their portfolio in Q3 2024
- AWM INVESTMENT COMPANY, INC. added 764,857 shares (+inf%) to their portfolio in Q3 2024
- NANTAHALA CAPITAL MANAGEMENT, LLC added 750,000 shares (+inf%) to their portfolio in Q3 2024
- AIGH CAPITAL MANAGEMENT LLC added 620,002 shares (+17.7%) to their portfolio in Q3 2024
- VELAN CAPITAL INVESTMENT MANAGEMENT LP added 517,668 shares (+inf%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
